Skip to content

LoFric® Origo™ 44410Recalls & reported problems

Wellspect AB · Single Use Urinary Catheter with salt solution. LoFric Origo, Tiemann 40cm CH10 / Coudé 16" 10FR, Sterile device. · Class 2

All models of LoFric Origo (12)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07333387043395), received between Mar 25, 2026 and Mar 25, 2026 — classified as 1 injury.

The most frequently reported specific device problem is “Off-Label Use” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Off-Label Use1

Patient problems

  • Bacterial Infection1
  • Hepatitis1
  • Rheumatoid Arthritis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 25, 2026Off-Label Use

    THE ADVERSE EVENT OCCURRED OUTSIDE US, IN SPAIN. THE (B)(6) HOSPITAL IN (B)(6) SPAIN, INDICATED US THAT THEY HAVE HAD AN INCREASE IN PROBLEMS WITH PATIENTS INSTILLED WITH BCG USING OUR CATHETERS, WHICH THEY STARTED BUYING IN 2025. THE CATHETERS USED ARE THE LOFRIC ORIGO TIEMANN MALE 40 CM (CH10 AND CH12); REF NUMBERS 4441000, 4441200 AND 4441280. BEFORE THE HOSPITAL USED TO USE ANOTHER MANUFACTURER'S PRODUCT, THE COLOPLAST NAVI. ACCORDING TO THE HOSPITAL THERE HAS BEEN A CONSIDERABLE INCREASE IN CASES OF BCGITIS SINCE THE SUMMER, IN TOTAL 3 CASES OF BCGITIS. THEY ALSO HAD 1 CASE OF HEPATITIS AND 1 CASE OF RHEUMATOID ARTHRITIS, WHICH BOTH REQUIRED HOSPITALIZATION. THIS DIDN'T HAPPEN TO THEM USING THE COLOPLAST NAVI CATHETERS. THE HOSPITAL HAS DECIDED TO PURCHASE AGAIN THE COLOPLAST NAVI CATHETERS FOR 3 MONTHS IN ORDER TO INVESTIGATE IF THE PROBLEMS DECREASE.

    Patient problems: Bacterial Infection; Hepatitis; Rheumatoid Arthritis

    MAUDE report 24686977 ↗

Other Catheter, straight devices

All Catheter, straight devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page